- Home
- QXO vs LNTH Comparison
QXO vs LNTH Comparison
Compare QXO & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QXO
- LNTH
- Stock Information
- Founded
- QXO 1988
- LNTH 1956
- Country
- QXO United States
- LNTH United States
- Employees
- QXO N/A
- LNTH N/A
- Industry
- QXO EDP Services
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- QXO Technology
- LNTH Health Care
- Exchange
- QXO Nasdaq
- LNTH Nasdaq
- Market Cap
- QXO 5.7B
- LNTH 5.7B
- IPO Year
- QXO N/A
- LNTH 2015
- Fundamental
- Price
- QXO $21.64
- LNTH $70.18
- Analyst Decision
- QXO Strong Buy
- LNTH Strong Buy
- Analyst Count
- QXO 6
- LNTH 5
- Target Price
- QXO $33.20
- LNTH $131.20
- AVG Volume (30 Days)
- QXO 12.7M
- LNTH 1.1M
- Earning Date
- QXO 08-13-2025
- LNTH 07-30-2025
- Dividend Yield
- QXO 121.01%
- LNTH N/A
- EPS Growth
- QXO N/A
- LNTH N/A
- EPS
- QXO N/A
- LNTH 3.53
- Revenue
- QXO $55,945,000.00
- LNTH $1,536,699,000.00
- Revenue This Year
- QXO $12,800.67
- LNTH $4.57
- Revenue Next Year
- QXO $58.99
- LNTH $9.41
- P/E Ratio
- QXO N/A
- LNTH $19.87
- Revenue Growth
- QXO 0.21
- LNTH 12.53
- 52 Week Low
- QXO $10.61
- LNTH $69.12
- 52 Week High
- QXO $157.28
- LNTH $122.83
- Technical
- Relative Strength Index (RSI)
- QXO 57.15
- LNTH 29.54
- Support Level
- QXO $20.69
- LNTH $69.12
- Resistance Level
- QXO $22.05
- LNTH $83.32
- Average True Range (ATR)
- QXO 0.75
- LNTH 3.02
- MACD
- QXO -0.22
- LNTH -0.99
- Stochastic Oscillator
- QXO 64.37
- LNTH 6.55
About QXO QXO Inc. Common Stock
QXO Inc provides technology solutions, primarily to clients in the manufacturing, distribution, and service sectors. It provides consulting and professional services, specialized programming, training, and technical support. It also offers solutions for accounting, financial reporting, enterprise resource planning, warehouse management systems, customer relationship management, business intelligence, and other applications.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.